News
For influenza A or B virus, the hazard ratio comparing LAIV with IIV was 1.03 (95% confidence interval, 0.85 to 1.24).
Researchers in the United States and Austria have demonstrated the potential of a modified influenza virus as a vaccine to protect against viral respiratory pathogens, including the novel severe ...
Piedra P, Gaglani M, Kozinetz C, et al. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A outbreak provided immediate, direct and ...
In the 2007-2008 flu season, the inactivated vaccine was more effective than the live attenuated vaccine in preventing laboratory-confirmed symptomatic influenza A (mostly H3N2) in healthy ...
Recently, a research team led by Prof. Si Longlong from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences has proposed a new live-attenuated influenza vaccine ...
In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself ...
The intranasal live attenuated influenza vaccine (LAIV), FluMist, has been widely appreciated by pediatricians, parents, and children alike for its ease of administration. However, concerns ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback